SEC Seal
SEC Banner
Search the Next-Generation EDGAR System
Filing Detail
Form 8-K - Current report:
SEC Accession No. 0000926617-20-000077
Filing Date
2020-11-12
Accepted
2020-11-12 17:10:46
Documents
7
Period of Report
2020-11-12
Items
Item 2.02: Results of Operations and Financial Condition
Item 5.02: Departure of Directors or Certain Officers; Election of Directors; Appointment of Certain Officers: Compensatory Arrangements of Certain Officers
Item 7.01: Regulation FD Disclosure
Item 9.01: Financial Statements and Exhibits

Document Format Files

Seq Description Document Type Size
1 8-K awh-20201112x8k.htm 8-K 52550
2 EX-99.1 awh-20201112xex99_1.htm EX-99.1 263030
3 EX-99.2 awh-20201112xex99_2.htm EX-99.2 17736
4 EX-99.3 awh-20201112xex99_3.htm EX-99.3 41536
5 GRAPHIC awh-20201112xex99_1g001.jpg GRAPHIC 135062
6 GRAPHIC awh-20201112xex99_2g001.jpg GRAPHIC 135062
7 GRAPHIC awh-20201112xex99_3g001.jpg GRAPHIC 135062
  Complete submission text file 0000926617-20-000077.txt   934862
Mailing Address 12117 BEE CAVES ROAD BUILDING THREE SUITE 100 AUSTIN TX 78738
Business Address 12117 BEE CAVES ROAD BUILDING THREE SUITE 100 AUSTIN TX 78738 512-519-0400
Aspira Women's Health Inc. (Filer) CIK: 0000926617 (see all company filings)

IRS No.: 330595156 | State of Incorp.: DE | Fiscal Year End: 1231
Type: 8-K | Act: 34 | File No.: 001-34810 | Film No.: 201307937
SIC: 2835 In Vitro & In Vivo Diagnostic Substances